Menu

Shares Magazine

Magazine
- Back
- Latest Issue: 19 Dec 2024
- Archives
  
  12 Dec 2024
  
  05 Dec 2024
  
  28 Nov 2024
  
  21 Nov 2024
  View all
- More Reading
Tools
- Back
- Market Data
  - Back
  - Share Prices
  - Indices
  - Funds
  - Forex
  - IPOs
  - Market Diary
- Market Tools
  - Back
  - Portfolio
  - Stockwatch
  - Market Scan
  - Charts
  - Alerts
- Director Deals
  - Back
  - Director Deals
  - Latest Deals
  - Analysis
  - Search
  - Alerts
News
- Back
- Shares News
  Shares journalists news and views on today's breaking stories.
- Market & Company News
  A comprehensive daily news service of over 300 market and company stories from Alliance News and the RNS.
Awards
- Back
- Investment Awards
  
  The AJ Bell Investment Awards is your chance to vote for your pick of active and passive funds.
Events
Videos
Podcasts
Contact us and help Subscribe

Search results for 'Ʊ׶ ĺ Ʊ׶.r-e.kr 50mg ˸ ī׶ ӽ'

Shares Comment Stock Quotes Videos Events

Filter

Loading filters...

Showing 531 to 538 of 538 |

Filter

Thumbs down to Hikma's injectables decision

Drug manufacturer Hikma Pharmaceuticals? (HIK) decision to keep its global injectables business has not been positively received by the market which had been expecting a large cash sale. The London-based generic and in-licensed...

17 April 2013
Funds: Ride the Asian dividend boom

Asia-Pacific equities expert Mike Kerley manages the £350 million Henderson Far East Income (HFEL), whose objective is to provide investors with a high level of dividends as well as long-term capital appreciation from investments...

21 February 2013
Throw your portfolio a Lifeline

Buy medical device specialist Lifeline Scientific (LSI:AIM) as the company enhances its products and extends its global reach to drive profits growth.The £18 million cap, a supplier of devices that preserve organs such as the liver...

14 February 2013
Around the world in 18 plays: Asia/Australasia

Asia offers investors valuable upside exposure to the prospect of a global economic recovery. But the region's domestic consumption-driven growth plays should also fare well if the green shoots in the US and Europe wither...

07 February 2013
Glaxo's acid test

Full-year results (6 Feb) from pharmaceutical giant GlaxoSmithKline (GSK) failed to excite the market as it met earnings expectations. The acid test for the £71 billion cap is staying on top of the game through responding to...

06 February 2013
GW is set for a fresh high

Buy cannabinoid-focused medicine company GW Pharmaceuticals (GWP:AIM) ahead of positive newsflow around its strategic development and commercial operations in 2013.The company, which develops drugs from cannabis plants to ease pain...

20 December 2012
Time for a strong dose of pharmaceuticals

It was a long time coming and when it finally came it arrived from Burton-on-Trent.On 25 September a new pharmaceutical stock was presented to investors when Clinigen (CLIN:AIM) became the first in the sector to list in London since...

13 December 2012
Three reasons to buy emerging markets

Stack them high and sell them cheap. And do not worry too much about rewarding your shareholders. Over the past several years, emerging market companies have enjoyed a lot of success operating under this business model. But the...

06 December 2012

< Previous

49 50 51 52 53 54

Showing 531 to 538 of 538

Most Read

1
The £1 billion profit club: Discover the titans of UK retail
2
Experts believe we are still in the early stages of the AI ‘revolution’
3
Why the tide is about to turn for Diageo
4
Top analyst software picks for 2025 phase of AI revolution
5
Reassessing the Scottish Mortgage investment case
6
Stock pick for 2025: market set to toast a Diageo recovery
7
Which stocks worked for Warren Buffett and other ‘super-investors’ this year?
8
Take advantage of International Biotechnology Trust’s big discount
9
Big returns from small caps: How the experts find the stars of the future and our three best ideas
10
Great value UK stocks: Where to find the biggest bargains

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

The latest company news
Insight into investment trends
Round-up of directors' buys and sells
Articles from Shares magazine

Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Your email address *

Shares Magazine Latest Issue Cover

Latest Issue:
19 Dec 2024 Subscribe now

Market Overview

UK 350 Risers and Fallers

Terms And Conditions Investment Warning Privacy Disclaimers Cookies About Shares The Shares Team Contact Us

X Cookie Policy

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies from this website. You may change your preferences at any time.

Submitting...